Literature DB >> 25122420

An evidence-based determination of issues affecting quality of life and patient-reported outcomes in lung cancer: results of a survey of 660 patients.

Richard J Gralla1, Patricia J Hollen, Pavlos Msaouel, Beverly Vincent Davis, Judith Petersen.   

Abstract

INTRODUCTION: Identifying issues of importance for patients with lung cancer is critical in individualizing care and developing effective quality of life instruments based on evidence. This study was conducted to provide enhanced content validity for measures assessing quality of life and patient-reported outcomes (PROs).
METHODS: We conducted an anonymous, cross-sectional, electronic web-based survey of 660 lung cancer patients. The survey asked patients to rank 20 quality of life issues on a 5-point scale ranging from "not important at all" to "very important". Analysis was obtained using key factors such as stage of disease, performance status, and gender.
RESULTS: The survey was completed by 297 males and 363 females (median age 62 years). The top five rated issues were: quality of life, maintaining independence, ability to perform normal activities, ability to sleep, and not being fatigued. The issues of importance were all ranked, using the two highest categories ("very important" and "important") by at least 90% of patients. Although symptoms are important to patients, they were not the most highly ranked issues of concern; instead, global issues illustrating the effect of the symptoms on the patient, such as quality of life, maintaining independence, and performing normal activities were ranked highest.
CONCLUSIONS: This is the largest analysis of evidence-based data determining content validity for quality of life and PROs as indicated by patients. These results provide greater confidence that the content of lung cancer quality of life measures is appropriate. In addition, the survey clearly demonstrates that PRO measures that only evaluate symptoms are not fully responding to patient-expressed needs.

Entities:  

Mesh:

Year:  2014        PMID: 25122420     DOI: 10.1097/JTO.0000000000000244

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  13 in total

1.  Quality of life for non-small cell lung cancer patients in the age of immunotherapy.

Authors:  Robert A Ramirez; Jonathan Lu; Katharine E H Thomas
Journal:  Transl Lung Cancer Res       Date:  2018-04

Review 2.  Health Social Media and Patient-Centered Care: Buzz or Evidence? Findings from the Section "Education and Consumer Health Informatics" of the 2015 Edition of the IMIA Yearbook.

Authors:  P Staccini; L Fernandez-Luque
Journal:  Yearb Med Inform       Date:  2015-08-13

3.  Exercise capacity and cancer-specific quality of life following curative intent treatment of stage I-IIIA lung cancer.

Authors:  Duc Ha; Andrew L Ries; Peter J Mazzone; Scott M Lippman; Mark M Fuster
Journal:  Support Care Cancer       Date:  2018-02-10       Impact factor: 3.603

4.  Trajectory of insomnia symptoms in older adults with lung cancer: using mixed methods.

Authors:  Grace E Dean; Patricia Ziegler; Hongbin Chen; Lynn M Steinbrenner; Suzanne S Dickerson
Journal:  Support Care Cancer       Date:  2018-10-15       Impact factor: 3.603

5.  Key issues affecting quality of life and patient-reported outcomes in prostate cancer: an analysis conducted in 2128 patients with initial psychometric assessment of the prostate cancer symptom scale (PCSS).

Authors:  Pavlos Msaouel; Richard J Gralla; Randy A Jones; Patricia J Hollen
Journal:  BMJ Support Palliat Care       Date:  2017-02-06       Impact factor: 3.568

6.  Do Patients Regret Having Received Systemic Treatment for Advanced Non-Small Cell Lung Cancer: A Prospective Evaluation.

Authors:  Patricia J Hollen; Richard J Gralla; Ryan D Gentzler; Richard D Hall; Bethany Coyne; Haiying Cheng; Balazs Halmos; Jane Gildersleeve; Claudia Calderon; Ivora Hinton; Geoffrey Weiss; Jeffrey Crawford; Jane Cerise; Martin Lesser
Journal:  Oncologist       Date:  2020-11-10

7.  A randomized trial of the electronic Lung Cancer Symptom Scale for quality-of-life assessment in patients with advanced non-small-cell lung cancer.

Authors:  J C Kuo; D M Graham; A Salvarrey; F Kassam; L W Le; F A Shepherd; R Burkes; P J Hollen; R J Gralla; N B Leighl
Journal:  Curr Oncol       Date:  2020-05-01       Impact factor: 3.677

8.  Effects of curative-intent lung cancer therapy on functional exercise capacity and patient-reported outcomes.

Authors:  Duc Ha; Andrew L Ries; Scott M Lippman; Mark M Fuster
Journal:  Support Care Cancer       Date:  2020-01-21       Impact factor: 3.603

9.  Prognosis in metastatic lung cancer: vitamin D deficiency and depression-a cross-sectional analysis.

Authors:  Daniel C McFarland; Madalyn Fernbach; William S Breitbart; Christian Nelson
Journal:  BMJ Support Palliat Care       Date:  2020-08-27       Impact factor: 4.633

10.  Preliminary Efficacy and Safety of Reishi & Privet Formula on Quality of Life Among Non-Small Cell Lung Cancer Patients Undergoing Chemotherapy: A Randomized Placebo-Controlled Trial.

Authors:  Jie Liu; Jun J Mao; Susan Qing Li; Hongsheng Lin
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.